See below for current clinical trials

For more information about a specific clinical trial, contact the study coordinator listed below. Please do not send personal or medical information unprotected over the Internet.

Name of Study: GC45428: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of GDC-8264 In Preventing Cardiac Surgery-Associated Acute Kidney Injury And Major Adverse Kidney Events

PI: Narendra Sastry, MD

Study Description: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study

Goal/Aim of study: The purpose of this study is to compare the effects, good or bad, of GDC-8264 versus placebo on participants undergoing cardiac surgery who are at moderate to high risk of CSA-AKI.

POC: Adam Zoble

EMAIL: Adam.Zoble@va.gov

PHONE: (813) 619-5131

Name of Study: An Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Effects of EDG-7500 in Adults with Hypertrophic Cardiomyopathy

PI: David Whitaker, MD

Study Description: A Phase II open label study

Goal/Aim of study: The purpose of this study is to learn about the safety and tolerability of an investigational study drug called EDG-7500 for the treatment of HCM.

POC: Adam Zoble

EMAIL: Adam.Zoble@va.gov

PHONE: (813) 619-5131